Ingersoll Rand Inc. Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Durable Growth: Year-to-date, organic orders are up 2% with a book-to-bill of 1.04x. Disciplined M&A has been a key driver, with 14 transactions closed and 9 additional transactions under LOI, averaging a 9.5x pre-synergy multiple.
• Value Creation: The value creation flywheel generates strong free cash flow, fueling disciplined capital deployment. Ownership mindset among employees drives outperformance.
• Innovation: Introduced the META Contact Cool Compressor in Europe, offering unmatched efficiency with 11% increase in flow, 40% less space, and 14% energy consumption reduction. Flexan in Life Science improved customer product yield rates.
• Tariff Impact: Incremental Section 232 tariffs and other increases affected margin guidance, with pricing actions taken but timing of realization impacting 2026.

Segment Performance

• Industrial Technology Segment (ITS): Third quarter orders rose 7%, with a book-to-bill of 0.99x for the quarter and 1.04x year-to-date. Organic order growth was in the low single digits. Revenue declined slightly year-over-year due to tough comparisons in renewable natural gas projects in the U.S. Adjusted EBITDA margins were 29%. Compressor orders were up high single digits, while industrial vacuum and blower, and power tools and lifting orders were up low single digits. Regional performance: Americas mid-single digits, Asia Pacific (China low single digits, rest mid-teens), EMEA (Europe, Middle East, India) high single digits down (driven by timing of industrial vacuum and blower business).
• Precision Technologies Segment (PST): Q3 orders were up 11% year-over-year with a book-to-bill of 1.01x. Organic orders were up 7%, with year-to-date organic order growth of 2% and a book-to-bill of 1.02x. Q3 revenue was up 5% year-over-year, driven by organic growth, foreign exchange, and M&A. PST delivered adjusted EBITDA of $128 million, up 8% year-over-year with a margin of 30.8%, improving 130 basis points sequentially and 80 basis points year-over-year. The Flexan product line in the Life Science business improved customer product yield rates from 55% to over 90%.

Guidance

• Total Revenue and Organic Volume: Full year guidance for total revenue and organic volume growth remains unchanged.
• Adjusted EBITDA: Midpoint of adjusted EBITDA guidance modified to $2.075 billion, driven by incremental Section 232 tariffs and other tariff increases, and delayed realization of pricing actions, partially offset by lower corporate costs.
• Adjusted EPS: Midpoint of adjusted EPS guidance reduced to $3.28 from $3.40.
• Segments: Expected adjusted EBITDA margin percentage flat sequentially compared to the third quarter. Adjusted tax rate expected to be roughly 23.5%, net interest expense about $220 million, CapEx around 2% of revenue. Share count updated to approximately 402 million shares.

Risks

• Tariff Uncertainty: Incremental Section 232 tariffs and timing of price realization pose risks to margin and EPS guidance.
• Macro Environment: Volatility in industrial end markets and tariff policies create uncertainty for execution and growth.
• Competitive Dynamics: Section 232 tariffs affect the competitive landscape and product pricing.

Question and Answer

• Q: Mike Halloran asks about end market momentum and margin confidence.

A: Vicente Reynal discusses positive order trends across regions, sequential improvements in ITS, and confidence in margin targets reaching 30% adjusted EBITDA margins by 2027.

• Q: Julian Mitchell inquires about margin headwinds and 2026 margin expectations.

A: Vikram Kini talks about tariff impact, organic volume deleverage, and M&A margin profile, expecting muted impact in the first half of 2026.

• Q: Jeffrey Sprague asks about tariff gross headwind and impact on 2026.

A: Vikram Kini states the in-year tariff inflation is over $100 million, with pricing actions and operational mitigation efforts to address it.

• Q: Andrew Kaplowitz asks about clean energy vertical in ITS and PST orders.

A: Vicente Reynal notes clean energy remains a good end market with positive orders in Americas and India, and PST orders were evenly strong across the portfolio.

• Q: Nigel Coe asks about 2026 outlook and tariff impact.

A: Vicente Reynal is positive on 2026 outlook with positive backlog and MQL momentum, while Vikram Kini discusses combination of pricing and operational measures to address tariffs.